Capital Investment Counsel LLC raised its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 0.8% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,936 shares of the company’s stock after purchasing an additional 24 shares […]

Darwin Wealth Management LLC bought a new position in Eli Lilly and Company (NYSE:LLY – Free Report) in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 426 shares of the company’s stock, valued at approximately $378,000. Other large investors also recently added to or […]

OneAscent Wealth Management LLC purchased a new position in Eli Lilly and Company (NYSE:LLY – Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 452 shares of the company’s stock, valued at approximately $400,000. Other hedge funds and other institutional investors […]

Schear Investment Advisers LLC grew its holdings in Eli Lilly and Company (NYSE:LLY – Free Report) by 8.9% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 8,396 shares of the company’s stock after purchasing an additional 687 shares during the period. Eli Lilly and […]

Sargent Investment Group LLC lifted its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 2.5% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,626 shares of the company’s stock after buying an additional 63 shares during the quarter. Sargent […]